Why the dance between manufacturers and PBMs continues

There’s a simple reason why co-pay accumulators captured the industry’s attention when they rolled out in 2017: Healthcare is too damn expensive and co-pay accelerators, at least in theory, offered a financial workaround. 

Read the full article here.

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.